Johnson & Johnson (NYSE: JNJ) director receives 975 deferred share units

Rhea-AI Filing Summary

Johnson Paula A reported acquisition or exercise transactions in this Form 4 filing.

Johnson & Johnson director Paula A. Johnson received a grant of 975 Deferred Share Units (DSUs) tied to the company’s common stock. These DSUs were awarded at no cash cost and will be settled in cash when her board service ends, based on the then-current share value.

After this grant and related dividend-equivalent accruals, she holds a total of 5,359.3973 DSUs, which track the value of Johnson & Johnson common stock but do not involve immediate share purchases or sales.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Johnson Paula A

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	975	$0.00	--

Holdings After Transaction: Deferred Share Units — 5,359.397 shares (Direct, null)

Footnotes (1)

1. Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Key Figures

Deferred Share Units granted: 975.0000 units Total DSUs after transaction: 5359.3973 units Transaction price per DSU: $0.0000 per unit +1 more

4 metrics

Deferred Share Units granted 975.0000 units Grant to director Paula A. Johnson on 2026-04-23

Total DSUs after transaction 5359.3973 units Paula A. Johnson holdings following grant

Transaction price per DSU $0.0000 per unit Grant award under deferred fee plan

Underlying common shares 975.0000 shares Each DSU represents one share’s fair market value at settlement

Key Terms

Deferred Share Units, Amended and Restated Deferred Fee Plan for Directors, dividend equivalent rights, fair market value

4 terms

Deferred Share Units financial

"Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

Amended and Restated Deferred Fee Plan for Directors financial

"acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

dividend equivalent rights financial

"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

fair market value financial

"each DSU representing the fair market value of one share of Common Stock on the settlement date"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Paula A

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	04/23/2026		A		975		(1)	(1)	Common Stock	975	$0	5,359.3973(2)	D

Explanation of Responses:

1. Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Paula A. Johnson	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Johnson & Johnson (JNJ) report for Paula A. Johnson?

Johnson & Johnson reported that director Paula A. Johnson received 975 Deferred Share Units as a grant. These units are part of the company’s deferred fee plan for directors and are tied to the value of Johnson & Johnson common stock.

How many Deferred Share Units does Paula A. Johnson hold after this JNJ Form 4 filing?

Following the latest grant, Paula A. Johnson holds 5,359.3973 Deferred Share Units. This total includes the 975-unit award and dividend-equivalent rights that accrue on previously granted DSUs under Johnson & Johnson’s director deferred fee plan.

How and when are Paula A. Johnson’s Johnson & Johnson Deferred Share Units settled?

The Deferred Share Units granted to Paula A. Johnson are settled in cash upon termination of her directorship. Each DSU represents the fair market value of one share of Johnson & Johnson common stock on the settlement date, rather than delivering actual shares.

What does the 975-unit grant to Paula A. Johnson represent for JNJ shareholders?

The 975-unit grant represents a compensation award to director Paula A. Johnson under Johnson & Johnson’s Amended and Restated Deferred Fee Plan for Directors. It tracks the value of common stock but is paid in cash at the end of her board service.

Do Paula A. Johnson’s Deferred Share Units in JNJ include dividend equivalents?

Yes. The reported total of 5,359.3973 Deferred Share Units for Paula A. Johnson includes dividend equivalent rights. These accrue in connection with Johnson & Johnson’s quarterly dividend on the DSUs she already holds under the director deferred fee plan.